10/02/2026
Lancashire and South Cumbria ICB have now commissioned a service for the provision of weight loss medications, however we are deeply disappointed with the proposed provision.
The eligibility criteria for Lancashire and South Cumbria has been determined as follows:
* Live in an area identified as one of the most deprived based on the Government’s indices of multiple deprivation (IMD-1)
ALONGSIDE
* A body mass index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for people from minority ethnic family backgrounds)
AND have at least four of the following long-term conditions:
* Non-diabetic hyperglycaemia or type two diabetes
* Hypertension (high blood pressure)
* Dyslipidaemia
* Established cardiovascular disease
* Obstructive sleep apnoea (formally diagnosed)
The ICB have stated “The NHS has an obligation to commission services equitably, ensuring fair access to health support for those most in need. As NHS funds are limited, we are targeting this support initially at those from the most deprived areas of the region.”
Ribblesdale Primary Care Network (comprising of Pendleside Medical Practice, Sabden and Whalley Medical Group, The Castle Medical Group and Slaidburn Country Practice) are writing to the ICB to express our outrage and frustration at the inclusion of the deprivation element as this unfairly excludes our entire PCN population from this service.
For the ICB’s official statement please follow this link:
https://www.lancashireandsouthcumbria.icb.nhs.uk/news-and-media/latest-news/policy-regarding-weight-management-medication-tirzepatide-brand-name-mounjaro-lancashire-and-south-cumbria